199 related articles for article (PubMed ID: 34974449)
1. Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management.
Gallo P; Silletta M; De Vincentis A; Lo Prinzi F; Terracciani F; Di Fazio G; Flagiello V; Vespasiani Gentilucci U; Antonelli Incalzi R; Picardi A
Chemotherapy; 2022; 67(3):152-163. PubMed ID: 34974449
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
[TBL] [Abstract][Full Text] [Related]
4. Nutrition and exercise in the management of liver cirrhosis.
Toshikuni N; Arisawa T; Tsutsumi M
World J Gastroenterol; 2014 Jun; 20(23):7286-97. PubMed ID: 24966599
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia in cirrhosis: from pathogenesis to interventions.
Ebadi M; Bhanji RA; Mazurak VC; Montano-Loza AJ
J Gastroenterol; 2019 Oct; 54(10):845-859. PubMed ID: 31392488
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis.
Feng Z; Zhao H; Jiang Y; He Z; Sun X; Rong P; Wang W
Clin Nutr; 2020 Oct; 39(10):3132-3139. PubMed ID: 32057535
[TBL] [Abstract][Full Text] [Related]
7. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Acosta LF; Galuppo R; García CR; Villacorta E; Dugan A; Castellanos AL; Gedaly R; Lee JT
J Surg Res; 2019 Jun; 238():10-15. PubMed ID: 30721781
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma and sarcopenia: a narrative review.
Revoredo S; Del Fabbro E
Ann Palliat Med; 2023 Nov; 12(6):1295-1309. PubMed ID: 37872128
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments.
Marasco G; Serenari M; Renzulli M; Alemanni LV; Rossini B; Pettinari I; Dajti E; Ravaioli F; Golfieri R; Cescon M; Festi D; Colecchia A
J Gastroenterol; 2020 Oct; 55(10):927-943. PubMed ID: 32748172
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions.
Perisetti A; Goyal H; Yendala R; Chandan S; Tharian B; Thandassery RB
World J Gastroenterol; 2022 Jan; 28(4):432-448. PubMed ID: 35125828
[TBL] [Abstract][Full Text] [Related]
11. Plasma free amino acids are associated with sarcopenia in the course of hepatocellular carcinoma recurrence.
Sano A; Tsuge S; Kakazu E; Iwata T; Ninomiya M; Tsuruoka M; Inoue J; Masamune A
Nutrition; 2021 Apr; 84():111007. PubMed ID: 33745507
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia in Patients with Advanced Liver Disease.
Ponziani FR; Gasbarrini A
Curr Protein Pept Sci; 2018; 19(7):681-691. PubMed ID: 28462693
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
Kim YR; Park S; Han S; Ahn JH; Kim S; Sinn DH; Jeong WK; Ko JS; Gwak MS; Kim GS
Sci Rep; 2018 May; 8(1):7157. PubMed ID: 29740069
[TBL] [Abstract][Full Text] [Related]
14. Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization.
Koya S; Kawaguchi T; Hashida R; Hirota K; Bekki M; Goto E; Yamada M; Sugimoto M; Hayashi S; Goshima N; Yoshiyama T; Otsuka T; Nozoe R; Nagamatsu A; Nakano D; Shirono T; Shimose S; Iwamoto H; Niizeki T; Matsuse H; Koga H; Miura H; Shiba N; Torimura T
J Gastroenterol Hepatol; 2019 Mar; 34(3):580-588. PubMed ID: 30402913
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia and Frailty in Cirrhosis: Assessment and Management.
Bunchorntavakul C
Med Clin North Am; 2023 May; 107(3):589-604. PubMed ID: 37001955
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia and liver transplant: The relevance of too little muscle mass.
Kallwitz ER
World J Gastroenterol; 2015 Oct; 21(39):10982-93. PubMed ID: 26494955
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.
Meza-Junco J; Montano-Loza AJ; Baracos VE; Prado CM; Bain VG; Beaumont C; Esfandiari N; Lieffers JR; Sawyer MB
J Clin Gastroenterol; 2013; 47(10):861-70. PubMed ID: 23751844
[TBL] [Abstract][Full Text] [Related]
18. Malnourished cirrhotic patient: what should we do?
Sciarrone SS; Zanetto A; Russo FP; Germani G; Gambato M; Battistella S; Pellone M; Shalaby S; Burra P; Senzolo M
Minerva Gastroenterol (Torino); 2021 Mar; 67(1):11-22. PubMed ID: 33784807
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia in cirrhosis: A practical overview.
Dhaliwal A; Armstrong MJ
Clin Med (Lond); 2020 Sep; 20(5):489-492. PubMed ID: 32934043
[TBL] [Abstract][Full Text] [Related]
20. [An approach of nutritional management by enteral alimentation with an elemental diet in patients with severe liver injury (author's transl)].
Watanabe A; Hayashi S; Higashi T; Obata T; Nagashima H
Nihon Shokakibyo Gakkai Zasshi; 1979 Jun; 76(6):1295-305. PubMed ID: 224230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
